Pathology Companies, July 2014

Talk to Sam

+1 718 473 0872

Search for a company

All regions

You might be interested in: vaccine, drug, hospital, more »

About 200 Companies

Read our Company Profiles

Novartis Inc.

Switzerland

GlaxoSmithKline P.L.C.

United States

Eli Lilly and Co.

United States

Pfizer Inc.

United States

AstraZeneca PLC

United Kingdom

Johnson and Johnson

United States

GlaxoSmithKline PLC

United Kingdom

Abbott Laboratories

United States

Lilly and Co.

United States

Bayer AG

Germany

Medtronic Inc.

United States

Amgen Inc.

United States

Bristol-Myers Squibb Co.

United States

Biogen Idec

United States

LifeScan Inc.

United States

Terumo Corp.

Japan

Merck KGaA

Germany

Celgene Corp.

United States

Animas Corp.

United States

Icon Group

United States

Genzyme Corp.

United States

Gilead Sciences Inc.

United States

Boston Scientific Corp.

United States


About 5 600 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 55 - $ 9 995)

PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

  • $ 9 995
  • Industry report
  • April 2014
  • by Global Data

PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update Summary Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most ...

Russia Hiv/aids, Dalys

May 2013 $ 250

Cyprus Hiv/aids, Dalys

May 2013 $ 250

Gambia Gonorrhoea, Dalys

May 2013 $ 250

Moldova Chlamydia, Dalys

May 2013 $ 250

Angola Syphilis, Dalys

May 2013 $ 250

Bahamas Gonorrhoea, Dalys

May 2013 $ 250

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.